Related references
Note: Only part of the references are listed.Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial
Domenica M. Rubino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Wegovy (semaglutide): a new weight loss drug for chronic weight management
Gurdeep Singh et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2022)
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
Qingyang Shi et al.
LANCET (2022)
The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: A systematic review and meta-analysis
Malou A. H. Nuijten et al.
OBESITY REVIEWS (2022)
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Takashi Kadowaki et al.
LANCET DIABETES & ENDOCRINOLOGY (2022)
Clinical effectiveness of liraglutide on weight loss in South Koreans First real-world retrospective data on Saxenda in Asia
Joon Seok Park et al.
MEDICINE (2021)
Setmelanotide: First Approval
Anthony Markham
DRUGS (2021)
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial
Thomas A. Wadden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial
Melanie Davies et al.
LANCET (2021)
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John P. H. Wilding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial
Domenica Rubino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Clinical Impact of Liraglutide as a Treatment of Obesity
Heshma Alruwaili et al.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS (2021)
Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis
Ioannis Avgerinos et al.
DIABETES OBESITY & METABOLISM (2020)
Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial
Thomas A. Wadden et al.
OBESITY (2020)
Obesity in adults: a clinical practice guideline
Sean Wharton et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Obesity: global epidemiology and pathogenesis
Matthias Blueher
NATURE REVIEWS ENDOCRINOLOGY (2019)
A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years
Vishal Sharma et al.
OBESITY REVIEWS (2019)
Nutrition, Physical Activity, and Prescription of Supplements in Pre- and Post-bariatric Surgery Patients: a Practical Guideline
Mastaneh Rajabian Tabesh et al.
OBESITY SURGERY (2019)
Cardiovascular and Metabolic Heterogeneity of Obesity Clinical Challenges and Implications for Management
Ian J. Neeland et al.
CIRCULATION (2018)
Progress and challenges in anti-obesity pharmacotherapy
Daniel H. Bessesen et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity
R. Burcelin et al.
OBESITY REVIEWS (2017)
Obesity: Risk factors, complications, and strategies for sustainable long-term weight management
Sharon M. Fruh
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (2017)
Nutritional Recommendations for Adult Bariatric Surgery Patients: Clinical Practice
Shiri Sherf Dagan et al.
ADVANCES IN NUTRITION (2017)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY
W. Timothy Garvey et al.
ENDOCRINE PRACTICE (2016)
Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events A Systematic Review and Meta-analysis
Rohan Khera et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
European Guidelines for Obesity Management in Adults
Volkan Yumuk et al.
OBESITY FACTS (2015)
Surgery for weight loss in adults
Jill L. Colquitt et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
The Importance of Preoperative and Postoperative Physical Activity Counseling in Bariatric Surgery
Wendy C. King et al.
EXERCISE AND SPORT SCIENCES REVIEWS (2013)
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
A. Astrup et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Long-Term Persistence of Hormonal Adaptations to Weight Loss
Priya Sumithran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
Daphne P. Guh et al.
BMC PUBLIC HEALTH (2009)
Peptides that regulate food intake - Glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats
RR Schick et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study
ED Parker et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Share Paper
